4,000 Paid Subscribers Already Using Reliq Health Technologies’ New iUGO Care Program
Reliq Health Technologies Inc. (TSXV:RHT) has received 4,000 paid subscribers to its iUGO Care program. This gives the company a recurring monthly revenue of more than $200,000 a month. This means that the company will definitely reach its breakeven point in December this year.
iUGO Care deals in chronic care management, remote patient monitoring, and telemedicine, and was recently launched by the company. It is a digital health solution that provides high-quality virtual care – automatically collecting a patient’s vital signs, tracking medication, and reminding patients when to take medication through audible alerts. Patients may interact with their iUGO Care program verbally through the use of Bluetooth technology and a two-way voice hub. The iUGO Care cloud instantly alerts the clinical care team involved if a patient develops key warning signs, which allows clinicians to intervene before a health crisis can occur.
“We are excited to announce that we now have over 4,000 patients live on our iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “The onboarding of patients is starting to accelerate as we move forward with our roll out to over 40,000 patients with the two current contracts in Texas. We are also very pleased to announce that we have achieved another critical milestone, as the Company will reach breakeven in December 2017. We continue to focus our efforts on the front line care providers in the US who are serving the over 37 million Medicare and Medicaid patients who have two or more chronic diseases such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD) and congestive heart failure. This market will continue to grow as the population ages and expands and as pressure from lawmakers and insurers to reduce healthcare spending increases. Our iUGO Care platform allows healthcare providers to proactively manage complex chronic care patients in the lower cost community setting, reducing the need for costly acute interventions such as hospital stays, surgeries, long-term care admissions and ER visits.”
Tech Penny Stocks to Watch: Reliq Health Technologies (TSXV:RHT) (OTCQB:RQHTF)window.googletag = window.googletag || {cmd: []};googletag.cmd.push(function() {googletag.defineSlot('/59672724/native-msc-instream-1', ['fluid'], 'gpt-passback').addService(googletag.pubads());googletag.enableServices();googletag.display('gpt-passback');});googletag.cmd.push(function() { googletag.display('banner_ad_msc_MD-A4'); }); Reliq stock is trading up $0.065, or +16.61%, bringing the stock price to $0.51 currently ... [Read]
Tech Penny Stocks to Watch: Reliq Health Technologies (TSXV:RHT) (OTCQB:RQHTF)window.googletag = window.googletag || {cmd: []};googletag.cmd.push(function() {googletag.defineSlot('/59672724/native-msc-instream-1', ['fluid'], 'gpt-passback').addService(googletag.pubads());googletag.enableServices();googletag.display('gpt-passback');});googletag.cmd.push(function() { googletag.display('banner_ad_msc_MD-A4'); }); Reliq stock is trading down $0.05, or -9.43%, bringing the stock price to $0.48 currently ... [Read]
Tech Penny Stocks to Watch: Reliq Health Technologies (TSXV:RHT) (OTCQB:RQHTF)window.googletag = window.googletag || {cmd: []};googletag.cmd.push(function() {googletag.defineSlot('/59672724/native-msc-instream-1', ['fluid'], 'gpt-passback').addService(googletag.pubads());googletag.enableServices();googletag.display('gpt-passback');});googletag.cmd.push(function() { googletag.display('banner_ad_msc_MD-A4'); }); Reliq stock is trading down $0.385, or -51.33%, bringing the stock price to $0.365 currently ... [Read]
googletag.cmd.push(function() { googletag.display('banner_ad_msc_MD-A4'); });Reliq Health Technologies Inc. (TSXV:RHT) will be working with Canaccord Genuity Corp. (TSXV:CF) and Gravitas Securities Inc. (private) on a brokered private placement offering. Canaccord and Gravitas will be co-leading the private ... [Read]
Reliq Health Technologies Inc. (TSXV:$RHT) will be holding a conference call for investors to review the company’s progress and to answer any shareholder questions.googletag.cmd.push(function() { googletag.display('banner_ad_msc_MD-A4'); }); The conference call will be held on December ... [Read]
Recently, Reliq Health Technologies, Inc. (TSXV:$RHT) has seen its SuperTrend line drop below the current stock price. This signal can alert investors that the stock has possibly entered the ‘Sell’ territory. So what are the ... [Read]
Disclosure:
1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.
2) Market Jar Media Inc. has or expects to receive the following amounts indirectly from the following companies mentioned in this Article: Reliq Health Technologies Inc. Click here for important disclosures about fees.
3) The Article and content related to the profiled company represent the personal and subjective views of the Author of this article, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, Market Jar Media Inc. or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The author was paid by Native Ads Inc. for this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'ss terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Market Jar Media Inc. should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Market Jar Media Inc.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.
